Stelexis Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- January 08, 2019
- Vertical
- Cancer Therapeutics
- Funding URL
- View Funding Page
- Funding Amount:
- $43,000,000
Company Info
- Company Description
- Stelexis Therapeutics is a company utilizes pre-cancerous stem cells to discover and develop transformative therapies.
- Market
- Cancer Treatment
- Location
- New York, NY, USA
- Coinvestors
- Deerfield Partners